International Parkinson and Movement Disorder Society®
@movedisorder.bsky.social
MDS wishes to acknowledge the following Marquee Level supporters of the 2025 International Congress: Roche and Theravance Biopharma US. #MDSCongress
October 4, 2025 at 10:30 PM
MDS wishes to acknowledge the following Marquee Level supporters of the 2025 International Congress: Roche and Theravance Biopharma US. #MDSCongress
MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Amprion Inc., Association of Movement Disorder Advanced Practice Providers, BlueRock Therapeutics LP, Cala Health, Capsida Biotherapeutics, and ClearSky Medical Diagostics #MDSCongress
October 4, 2025 at 10:00 PM
MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Amprion Inc., Association of Movement Disorder Advanced Practice Providers, BlueRock Therapeutics LP, Cala Health, Capsida Biotherapeutics, and ClearSky Medical Diagostics #MDSCongress
MDS wishes to acknowledge the following Silver Level supporters of the 2025 International Congress: Abbott, Britannia Pharmaceuticals Ltd., Emalex Biosciences, Insightec, Ipsen Biopharmaceuticals, Inc., and Teva Pharmaceuticals. #MDSCongress
October 4, 2025 at 9:30 PM
MDS wishes to acknowledge the following Silver Level supporters of the 2025 International Congress: Abbott, Britannia Pharmaceuticals Ltd., Emalex Biosciences, Insightec, Ipsen Biopharmaceuticals, Inc., and Teva Pharmaceuticals. #MDSCongress
MDS wishes to acknowledge the following Gold Level supporters of the 2025 International Congress: Boston Scientific and PTC Therapeutics. #MDSCongress
October 4, 2025 at 9:00 PM
MDS wishes to acknowledge the following Gold Level supporters of the 2025 International Congress: Boston Scientific and PTC Therapeutics. #MDSCongress
MDS wishes to acknowledge the following Platinum Level supporters of the 2025 International Congress: Acadia Pharmaceuticals Inc., AskBio Inc., Biogen, H Lundbeck A/S, Medtronic, Merz Theraputics GmbH, and Supernus Pharmaceuticals. #MDSCongress
October 4, 2025 at 8:30 PM
MDS wishes to acknowledge the following Platinum Level supporters of the 2025 International Congress: Acadia Pharmaceuticals Inc., AskBio Inc., Biogen, H Lundbeck A/S, Medtronic, Merz Theraputics GmbH, and Supernus Pharmaceuticals. #MDSCongress
MDS wishes to acknowledge the following Diamond Level supporters of the 2025 International Congress: Amneal Pharmaceuticals and Abbvie. #MDSCongress
October 4, 2025 at 8:01 PM
MDS wishes to acknowledge the following Diamond Level supporters of the 2025 International Congress: Amneal Pharmaceuticals and Abbvie. #MDSCongress
Gain essential skills for both clinical practice and research: emerging therapies, advanced techniques, and refined diagnostic strategies that integrate test analysis with thorough clinical evaluation. https://loom.ly/2EcHutA
October 3, 2025 at 9:01 PM
Gain essential skills for both clinical practice and research: emerging therapies, advanced techniques, and refined diagnostic strategies that integrate test analysis with thorough clinical evaluation. https://loom.ly/2EcHutA
New consensus report on dystonia: Updated definition & classification with added clinical features, clarifications, and emphasis on biological heterogeneity. https://loom.ly/-jglkDU
The definition and classification of the dystonias: A new consensus report
Updates include additional clinical features, clarifications, emphasis on the extensive underlying biological heterogeneity across subtypes.
www.movementdisorders.org
October 3, 2025 at 1:06 PM
New consensus report on dystonia: Updated definition & classification with added clinical features, clarifications, and emphasis on biological heterogeneity. https://loom.ly/-jglkDU
#MDSCongress experts will review the most impactful recent publications in both clinical and basic neuroscience. Mdscongress.org
October 2, 2025 at 1:06 PM
#MDSCongress experts will review the most impactful recent publications in both clinical and basic neuroscience. Mdscongress.org
New study shows deep learning can classify tremors from hand-drawn spirals. https://loom.ly/xRbdldE
Deep learning-based artificial intelligence algorithm to classify tremors from hand-drawn spirals
Study affirms that hand-drawn spirals contain quantifiable features that can be leveraged by DL models.
www.movementdisorders.org
October 1, 2025 at 1:08 PM
New study shows deep learning can classify tremors from hand-drawn spirals. https://loom.ly/xRbdldE
New Moving Along issue: 40 years of MDS, dystonia classification, MDSgene updates, and more.
Read all the latest: https://loom.ly/tHQICZU
Read all the latest: https://loom.ly/tHQICZU
Moving Along 2025, issue 3
40 years of MDS: A look back through the newsletter
www.movementdisorders.org
September 30, 2025 at 9:02 PM
New Moving Along issue: 40 years of MDS, dystonia classification, MDSgene updates, and more.
Read all the latest: https://loom.ly/tHQICZU
Read all the latest: https://loom.ly/tHQICZU
Did you know Movement Disorders the first-ever video journal? Discover how this innovation helped establish consensus, and the field itself.
Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org
Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org
September 30, 2025 at 1:05 PM
Did you know Movement Disorders the first-ever video journal? Discover how this innovation helped establish consensus, and the field itself.
Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org
Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org
Junior Awardee Dr. Jung Hwan Shin discusses his journey through movement disorders and what led him to study specific neuronal sub-types within the STN. He shares his future hopes for DBS treatments and how he believes his research may contribute. https://loom.ly/2xVAI74
September 29, 2025 at 9:01 PM
Junior Awardee Dr. Jung Hwan Shin discusses his journey through movement disorders and what led him to study specific neuronal sub-types within the STN. He shares his future hopes for DBS treatments and how he believes his research may contribute. https://loom.ly/2xVAI74
Junior Awardee Dr. Lydia Chougar discusses her work combining neuroimaging with transcriptomics and PET maps to uncover the biological underpinnings of structural abnormalities in multiple system atrophy. https://loom.ly/SaQGrvM
September 29, 2025 at 7:15 PM
Junior Awardee Dr. Lydia Chougar discusses her work combining neuroimaging with transcriptomics and PET maps to uncover the biological underpinnings of structural abnormalities in multiple system atrophy. https://loom.ly/SaQGrvM
Gain the specialty skills to recognize hallmark clinical features, uncover diagnostic clues, and manage a variety of patients. https://loom.ly/NdaHSqA
September 29, 2025 at 1:06 PM
Gain the specialty skills to recognize hallmark clinical features, uncover diagnostic clues, and manage a variety of patients. https://loom.ly/NdaHSqA
2025 #MDSCongress controversy debates: Learn how to make a more informed choice when sharing research results with patients and how a biologically-based definition of PD may or may not accelerate therapeutic discovery. Mdscongress.org
September 26, 2025 at 1:06 PM
2025 #MDSCongress controversy debates: Learn how to make a more informed choice when sharing research results with patients and how a biologically-based definition of PD may or may not accelerate therapeutic discovery. Mdscongress.org
Visual examples are incredibly helpful for learning the different functional movement disorders and their mechanisms. This course uses patient videos to demonstrate how clinicians evaluate often-tricky diagnoses. https://loom.ly/axmgg-4
September 25, 2025 at 1:05 PM
Visual examples are incredibly helpful for learning the different functional movement disorders and their mechanisms. This course uses patient videos to demonstrate how clinicians evaluate often-tricky diagnoses. https://loom.ly/axmgg-4
Celebrating 40 Years of MDS — and the Women Who Paved the Way
As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org
As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org
September 24, 2025 at 1:06 PM
Celebrating 40 Years of MDS — and the Women Who Paved the Way
As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org
As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org
Infection can be the cause of any of the most prevalent movement disorder phenotypes (as shown). A survey of clinicians by the MDS IRMD Study Group indicated that knowledge of the more well-established associations prominently contributes to diagnosis. https://loom.ly/QaddO5I
September 23, 2025 at 1:05 PM
Infection can be the cause of any of the most prevalent movement disorder phenotypes (as shown). A survey of clinicians by the MDS IRMD Study Group indicated that knowledge of the more well-established associations prominently contributes to diagnosis. https://loom.ly/QaddO5I
Dr. Cecilia Tremblay discusses her recent study, which is this year's MDCP Research Article of the Year, highlighting the potential accuracy of hyposmia and RBD in predicting Lewy pathology. https://loom.ly/x-625g4
September 22, 2025 at 10:01 PM
Dr. Cecilia Tremblay discusses her recent study, which is this year's MDCP Research Article of the Year, highlighting the potential accuracy of hyposmia and RBD in predicting Lewy pathology. https://loom.ly/x-625g4
Dr. Charulata Sankhla discusses the main findings of this year's MDCP Review Article of the Year, which covers the current status and diagnosis of subacute sclerosing panencephalitis (SSPE). https://loom.ly/uafZc2g
September 22, 2025 at 9:36 PM
Dr. Charulata Sankhla discusses the main findings of this year's MDCP Review Article of the Year, which covers the current status and diagnosis of subacute sclerosing panencephalitis (SSPE). https://loom.ly/uafZc2g
Attend the Video Challenge, MDS’s most popular event, at the #MDSCongress. Register today. mdscongress.org
September 22, 2025 at 1:06 PM
Attend the Video Challenge, MDS’s most popular event, at the #MDSCongress. Register today. mdscongress.org
MDS is planning for 2026, and your feedback is important. Help guide the future of our educational offerings. https://loom.ly/qSx50w8
MDS-0725-434: MDS Education Needs Assessment 2026
Take this survey powered by surveymonkey.com. Create your own surveys for free.
www.surveymonkey.com
September 19, 2025 at 1:06 PM
MDS is planning for 2026, and your feedback is important. Help guide the future of our educational offerings. https://loom.ly/qSx50w8
International collaboration has helped advance our understanding of movement disorders. Learn about global successes and strategies to address current gaps in global access to research and care. Mdscongress.org
September 18, 2025 at 1:06 PM
International collaboration has helped advance our understanding of movement disorders. Learn about global successes and strategies to address current gaps in global access to research and care. Mdscongress.org
This year’s #mdscongress theme celebrates the future of disease-modifying therapies and the many areas of investigation designated to achieving this goal within the field of PD.
September 17, 2025 at 1:07 PM
This year’s #mdscongress theme celebrates the future of disease-modifying therapies and the many areas of investigation designated to achieving this goal within the field of PD.